- |||||||||| budesonide / Generic mfg.
Clinical, Journal, HEOR: Comparative effectiveness of budesonide inhalation suspension and montelukast in children with mild asthma in Korea. (Pubmed Central) - Apr 20, 2021 Asthma-related total health-care costs were higher with MON versus BIS (₩ 190,185 vs. ₩ 167,432, respectively; p < .001), likely driven by higher pharmaceutical costs associated with MON (₩ 69,113 vs. ₩ 49,225; p < .001). Montelukast patients had better adherence, a longer time to loss of persistency, and were less likely to experience an exacerbation-related office visit in the post-index period than BIS patients.
- |||||||||| Keytruda (pembrolizumab) / Merck (MSD)
Journal: An unusual digestive complication under anti-PD-1 (pembrolizumab) (Pubmed Central) - Apr 20, 2021 The patient was initially successfully treated with corticosteroids (prednisone) and temporary interruption of pembrolizumab...The treatment was switched to budesonide, leading to a complete and definitive resolution of diarrhea...Currently, there is a bone progression treated by radiotherapy alone. In case of a more important progression, a systemic treatment will be secondarily discussed.
- |||||||||| budesonide / Generic mfg.
Clinical, Journal: Covid-19: Budesonide shortens recovery time in patients not admitted to hospital, study finds. (Pubmed Central) - Apr 14, 2021 Thus, our results provide a mechanistic basis for the use of the herbal combination of myrrh, coffee charcoal and chamomile flower extract in IBD treatment and underline the potential benefits of the phytotherapeutic multi-component/multi-target approach in this complex pathogenesis. No abstract available
- |||||||||| budesonide / Generic mfg.
Journal: The Budesonide-Hydroxypropyl-β-Cyclodextrin Complex Attenuates ROS Generation, IL-8 Release and Cell Death Induced by Oxidant and Inflammatory Stress. Study on A549 and A-THP-1 Cells. (Pubmed Central) - Apr 13, 2021 We also demonstrated (i) the involvement of the canonical molecular pathway including ROS generation, a decrease in PI3K/Akt activation, and decrease in phosphorylated/unphosphorylated HDAC2 in the effect induced by BUD:HPβCD, (ii) the maintenance of IL-8 decrease with BUD:HPβCD, and (iii) the absence of improvement in glucocorticoid insensitivity with BUD:HPβCD in comparison with BUD, in conditions where HDAC2 was inhibited. Resulting from HPβCD antioxidant and anticytotoxic potential and protective capacity against ROS-induced PI3K/Akt signaling and HDAC2 inhibition, BUD:HPβCD might be more beneficial than BUD alone in a context of concomitant oxidative and inflammatory stress.
- |||||||||| budesonide / Generic mfg.
Journal: A new kid on the budesonide block. (Pubmed Central) - Mar 16, 2021 Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance. No abstract available
|